Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Krouse, John H.
2004.
Inflammatory sinonasal disease.
Facial Plastic Surgery Clinics of North America,
Vol. 12,
Issue. 4,
p.
407.
van Cauwenberge, P.
Van Hoecke, H.
Vandenbulcke, L.
Van Zele, T.
and
Bachert, C.
2005.
Glucocorticosteroids in Allergic Inflammation: Clinical Benefits in Allergic Rhinitis, Rhinosinusitis, and Otitis Media.
Immunology and Allergy Clinics of North America,
Vol. 25,
Issue. 3,
p.
489.
Al Sayyad, JJ
Alhashimi, D
Fedorowicz, Z
Jamal, A
and
Al Sayyad, Jamal
2005.
Cochrane Database of Systematic Reviews.
Walls, Ronald S
Heddle, Robert J
Tang, Mimi L K
Basger, Ben J
Solley, Graham O
and
Yeo, Guan T
2005.
Optimising the management of allergic rhinitis: an Australian perspective.
Medical Journal of Australia,
Vol. 182,
Issue. 1,
p.
28.
Verret, D. J.
and
Marple, Bradley F.
2005.
Effect of topical nasal steroid sprays on nasal mucosa and ciliary function.
Current Opinion in Otolaryngology & Head and Neck Surgery,
Vol. 13,
Issue. 1,
p.
14.
Campos Pérez, I.
Carrasco Serrano, A.
and
Espinosa Sánchez, J.M.
2005.
Tratamiento de la rinitis alérgica y vasomotora. Una actualización basada en la evidencia.
FMC - Formación Médica Continuada en Atención Primaria,
Vol. 12,
Issue. 2,
p.
113.
Djupesland, Per Gisle
Skretting, Arne
Winderen, Mette
and
Holand, Trond
2006.
Breath Actuated Device Improves Delivery to Target Sites Beyond the Nasal Valve.
The Laryngoscope,
Vol. 116,
Issue. 3,
p.
466.
2006.
Wiley Handbook of Current and Emerging Drug Therapies.
Mygind, Niels
and
Andersson, Morgan
2006.
Topical glucocorticosteroids in rhinitis: clinical aspects.
Acta Oto-Laryngologica,
Vol. 126,
Issue. 10,
p.
1022.
Kim, Kenneth
Weiswasser, Michael
Nave, Ruediger
Ratner, Paul
Nayak, Anjuli
Herron, Jerry
Hall, Nancy
and
Wingertzahn, Mark
2007.
Safety of Once-Daily Ciclesonide Nasal Spray in Children 2 to 5 Years of Age with Perennial Allergic Rhinitis.
Pediatric Asthma, Allergy & Immunology,
Vol. 20,
Issue. 4,
p.
229.
Chervinsky, Paul
Kunjibettu, Sudeesha
Miller, David L.
Prenner, Bruce M.
Raphael, Gordon
Hall, Nancy
and
Shah, Tushar
2007.
Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.
Annals of Allergy, Asthma & Immunology,
Vol. 99,
Issue. 1,
p.
69.
Schwabe, Ulrich
2007.
Arzneiverordnungs-Report 2006.
p.
105.
Meltzer, Eli O.
2007.
Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
Annals of Allergy, Asthma & Immunology,
Vol. 98,
Issue. 1,
p.
12.
Hamann, Karl-Friedrich
2007.
Arzneiverordnungs-Report 2006.
p.
869.
Berger, William E
Godfrey, James W
and
Slater, Anna L
2007.
Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
Expert Opinion on Drug Delivery,
Vol. 4,
Issue. 6,
p.
689.
Wang, Heyao
Zhang, Jiali
Gao, Chunsheng
Zhu, Ying
Wang, Chen
and
Zheng, Wenjie
2007.
Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis.
European Journal of Pharmacology,
Vol. 577,
Issue. 1-3,
p.
162.
Meltzer, Eli O.
Kunjibettu, Sudeesha
Hall, Nancy
Wingertzahn, Mark A.
Murcia, Crystal
Berger, William
and
LaForce, Craig
2007.
Efficacy and safety of ciclesonide, 200 μg once daily, for the treatment of perennial allergic rhinitis.
Annals of Allergy, Asthma & Immunology,
Vol. 98,
Issue. 2,
p.
175.
Al Sayyad, Jamal J
Fedorowicz, Zbys
Alhashimi, Dunia
and
Jamal, Ahmed
2007.
Topical nasal steroids for intermittent and persistent allergic rhinitis in children.
Cochrane Database of Systematic Reviews,
Vol. 2009,
Issue. 1,
Rosenblut, A.
Bardin, P. G.
Muller, B.
Faris, M. A.
Wu, W. W.
Caldwell, M. F.
and
Fokkens, W. J.
2007.
Long‐term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Allergy,
Vol. 62,
Issue. 9,
p.
1071.
Baldwin, Claudine M
and
Scott, Lesley J
2008.
Mometasone Furoate.
Drugs,
Vol. 68,
Issue. 12,
p.
1723.